Methotrexate for Psoriasis: A New Therapeutic Schedule

Archives of Dermatology

Volumn 103, Issue 1, 1971, Pages 33-38

  Weinstein, Gerald D ^a   Frost, Phillip ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ALOPECIA; ARTICLE; HUMAN; IATROGENIC DISEASE; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; MOUTH DISEASE; NAUSEA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROGNOSIS; PSORIASIS; THROMBOCYTOPENIA; ULCER; URTICARIA;

ADMINISTRATION, ORAL; ALOPECIA; HUMAN; INJECTIONS, INTRAMUSCULAR; LEUKOPENIA; METHOTREXATE; MOUTH DISEASES; NAUSEA; PROGNOSIS; PSORIASIS; THROMBOCYTOPENIA; ULCER; URTICARIA;

EID: 0014981957     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1971.04000130035004     Document Type: Article

References (15)

1. Rees RB, Bennett JH, Maibach HI, et al: Methotrexate for psoriasis. Arch Derm 95:2-11, 1967.
2. Van Scott EJ, Auerbach R, Weinstein GD: Parenteral methotrexate in psoriasis. Arch Derm 89:550-556, 1964.
3. Roenigk HH, Fowler-Bergfeld W, Curtis GH: Methotrexate for psoriasis in weekly oral doses. Arch Derm 99:86-93, 1969.
4. Weinstein GD, Frost P: Abnormal cell proliferation in psoriasis. J Invest Derm 50:254-259, 1968.
5. Skipper HE: Biochemical, biological, pharmacologic, toxicologic, kinetic and clinical relationships. Cancer 21:600-610, 1968.
6. Bruce WR, Meeker BE, Valeriote FA: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Nat Cancer Inst 37:233-245, 1966.
7. Merkle TC, Stuart RN, Gofman JW: The Calculation of Treatment Schedules for Cancer Chemotherapy. UCRL-14505, Biology and Medicine, UC-48, TID-4500 Livermore, Calif, Dept of Health, Education, and Welfare.
8. Van Scott EJ, Ekel TM, Auerbach R: Determinants of rate and kinetics of cell division on scalp hair. J Invest Derm 41:269-273, 1963.
9. Berlin NI, Rall D, Mead JAR, et al: Folic acid antagonists: Effects on the cell and the patient. Ann Intern Med 59:931-956, 1963.
10. Weinstein GD, Frost P: Cell Proliferation Kinetics in Benign and Malignant Skin Diseases in Humans, monograph 30. Public Health Service, 1969, pp 225-246.
11. Weinstein GD, Cox JW, Suringa DWR, et al: Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Arch Derm, to be published.
12. Prescott DM: Regulation of cell reproduction. Cancer Res 28:1815-1820, 1968.
13. Weinstein GD, Goldfaden G, Frost P: The effect of methotrexate on DNA synthesis in psoriasis, abstract. Clin Res 18:353, 1970.
14. Nyfors A, Brodthagen H: Methotrexate for psoriasis in weekly oral doses without any adjunctive therapy. Dermatologica 140:345-355, 1970.
15. Henderson ES, Adamson RH, Oliverio VT: The metabolic fate of tritiated methotrexate: II. Absorption and excretion in man. Cancer Res 25:1018-1024, 1965.